WO1994006379A1 - Receptive condom assembly - Google Patents
Receptive condom assembly Download PDFInfo
- Publication number
- WO1994006379A1 WO1994006379A1 PCT/US1993/008938 US9308938W WO9406379A1 WO 1994006379 A1 WO1994006379 A1 WO 1994006379A1 US 9308938 W US9308938 W US 9308938W WO 9406379 A1 WO9406379 A1 WO 9406379A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- condom
- sheath
- insertion tube
- applicator
- tube
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/065—Condom-like devices worn by females
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/917—Body fluid, devices for protection therefrom, e.g. aids, hepatitus
- Y10S128/918—Condoms and shields
Definitions
- This invention relates to the field of contraception and to the control of venereal disease transmission, including Acquired Immune Deficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) infection.
- AIDS Acquired Immune Deficiency Syndrome
- HIV Human Immunodeficiency Virus
- this invention relates to an improved receptive condom assembly for use by a passive sexual partner.
- Female contraceptives are generally divided into four basic types which include orally administered pharmaceuticals; the cervical cap; devices which rely on chemical spermicides, such as diaphragms, sponges, foams, jellies, dermal implants and suppositories; and the intrauterine device. These contraceptives, however, suffer from a number of serious disadvantages.
- oral contraceptives Although effective in preventing conception, oral contraceptives reportedly have various undesirable side effects, including possible implication in carcinogenic damage to the gall bladder and liver.
- the diaphragm while reliable when correctly used, is a cumbersome and inconvenient contraceptive that can easily interrupt or detract from the act of intercourse.
- Spermicidal contraceptives are also inconvenient to use and may be only as much as 85% reliable as a contraceptive.
- the cervical cap cannot be fitted on some women, and on women who are able to wear it, it may produce discomfort and infection.
- the intrauterine device has been the subject of much public controversy and has been reported to be unsafe under certain circumstances.
- female contraception do not provide adequate and independent protection from sexually transmitted diseases. Although spermicidal implants may provide some protection, the available female contraceptives do not provide a reliable impermeable barrier to infection vectors such as HIV.
- the male condom is the usual form of contraceptive available to men. It is also the most reliable protection against sexually transmitted disease that is currently available to either sex, even though the male condom may have a failure rate as high as 17%.
- the male condom especially when made of latex, provides an effective membrane barrier against the transmission of infection. Additionally, the present male condom is widely available, economical, does not require a doctor's services, and does not normally cause any side effects to either partner.
- the conventional male condom comprises an elongated tubular sheath made of thin, flexible material such as latex film.
- the sheath is closed at one end and open at the other end to provide for the insertion of a penis.
- the opening includes a periphery having a beaded or constricted ' rim.
- the condom is put on by rolling it onto or pulling it onto an erect penis.
- the latex-type condom fits tightly in order to be kept in place during intercourse.
- U.S. Patent No. 4,805,604 describes a receptive condom device adapted to be received by a passive sexual organ prior to intercourse.
- the device consists of a thin elastic membrane sheath having a closed end, a supporting ring structure at its open end, and an insertion tube adapted to deliver the condom to a passive sexual organ prior to intercourse.
- a charge of compressed air in communication with the inside of the condom, forces the condom out of the tube end into the passive sexual organ closed end first. The collapsed charge and insertion tube are then removed, leaving the condom in place. While the condom device is satisfactory for its intended use, the described method of application could be improved.
- U.S. Patent No. 4,867,176 describes a female condom and a disposable tampon-like applicator device adapted to facilitate vaginal insertion.
- the condom is inserted into the vagina using the applicator fitted with a broad tip portion which is received in the closed distal end of the condom.
- the applicator is then removed, leaving the condom in place.
- the disadvantages of the described device is that applicator is cumbersome and may inadvertently rip or tear the condom during insertion into the vagina or pull the condom out from the vagina during removal of the applicator device.
- U.S. Patent Nos. 4,945,923 and 4,976,273 describe a vaginal sheath having flexible rings at both the top open and bottom closed ends. The bottom ring portion of the sheath is inserted into the vagina for anchoring against the cervix like a diaphragm.
- the disadvantages of the described devices are that they are cumbersome and difficult to fit. Moreover, it is also known that such devices are difficult to correctly insert into the vagina. See, for example, E.H. in "Mirabella, " August 1992, page 70 and F. Vrazo in "New York Daily News," January 22, 1990. Accordingly, there is a need in the art for a simple and convenient condom assembly and method of application for a sexually passive partner which overcomes at least some of the aforementioned deficiencies in conventional devices.
- the present invention provides a receptive condom assembly adapted to be worn by the sexually passive partner, e.g., male or female, comprising a condom and an insertion element.
- the receptive condom assembly may include an optional applicator element.
- the condom comprises a thin elastic sheath that is closed at one end and open at the other and which has a generally phallic shape.
- the sheath is sized to fill and line the passive sexual organ of the passive partner, receive a penis at the open end, yield to a penis within the passive sexual organ, and enclose without actively gripping the penis.
- a passive sexual organ is any organ which receives an erect penis during sexual relations (e.g.., intercourse) .
- a sheath having a supporting double ring structure such as the one described in my prior U.S. Patent no.4,805, 604, may be used in the condom assembly of the present invention.
- the sheath is provided with a cushioning outer ring of soft, smooth rubber at the open end.
- the outer cushioning ring surrounds a thin, inflexible (but not hard) rubber inner ring, which fits on the outside of the opening of a passive sexual organ.
- the purpose of the inflexible inner ring is to provide rigidity, so that the soft rubber outer ring does not fold or buckle and get pushed or pulled inside the passive sexual organ during sexual relations.
- the receptive condom sheath and ring may also be sized for comfort, for example within a range of at least five sizes - petite, small, medium, large, and extra large. The size needed is determined by the size of the opening of the passive sexual organ.
- the double ring structure may encircle and rest around the base of the penis when penetration is completed, forming a barrier against leakage of seminal fluids over the ring and out of the open end of the condom.
- the double ring structure will create a seal around the base of the penis, thereby holding the sheath in place over the penis during sexual relations, without requiring the sheath to fit tightly.
- the double ring structure prevents the receptive condom from being pushed into the passive sexual organ.
- the present invention provides a sheath which is attached to and within a cushioning ring at a location midway between the inner and outer circumferences of the cushioning ring.
- a sheath which is attached to and within a cushioning ring at a location midway between the inner and outer circumferences of the cushioning ring.
- the cushioning ring may be optionally provided with a thin, inflexible (but not hard) rubber inner ring, such as one described in my prior U.S. Patent No. 4,805,604.
- Other receptive sheaths or unisex condoms may be used in the condom assembly of the present invention such as the ones described in U.S. Patent No.4,805,604; 4,945,923 and 4,976,273.
- the condom assembly of the present invention includes an insertion element for inserting the condom sheath, closed end first, into the passive sexual organ of a passive partner.
- the insertion element comprises a shape-retaining insertion housing tube having an open rear end and a front end which may be open or closed. The front end of the insertion tube is adapted to receive the condom closed end first.
- the insertion tube comprises a water soluble, shape- retaining film of sufficient rigidity to facilitate insertion of the insertion tube into the passive sexual organ front end first. After insertion, the insertion tube remains within the passive sexual organ and readily dissolves on contact with the moist mucous surface lining of the passive sexual organ to form a liquid or gel.
- the insertion tube is made from any suitable biocompatible, water soluble, shape-retaining material such as natural or synthetic polymers and should not cause mucous membrane irritation.
- suitable, but non-limiting, materials for making the insertion element of the invention include gelatin and gelatin-containing mixtures such as gelatin, polyvinyl alcohol, and glycerin such as described for VCF (Vaginal Contraceptive Film) , a female contraceptive film produced by Apothecus, Inc. (New York, USA) .
- a preferred material for use in the invention is gelatin.
- the insertion tube may also contain bioactive materials such as spermicidal, anti-viral or anti-bacterial agents.
- Such materials may be incorporated into the insertion tube as a surface coating or may be mixed into the water soluble shape-retaining material. If desired, water or a water-based lubricant may be applied to the outer surface of insertion element as a coating to facilitate insertion of the condom into the passive sexual organ. This coating is applied to the insertion tube just prior to insertion to prevent premature dissolution of the insertion tube.
- the condom assembly of the present invention may also include an applicator element. In this embodiment, an assembly of the applicator element, an insertion element, and a condom (discussed above) housed within the insertion element is contemplated.
- the applicator element comprises an applicator tube having an open rear end adapted to receive and surround a portion of a finger and a closed front end which is adapted to be inserted into the rear open end portion of the insertion tube.
- the applicator tube in communication with the finger, confronts the front end portion of the condom and is co-axially aligned with the insertion tube.
- the applicator tube facilitates the insertion of the insertion tube (front end first) into the passive sexual organ by a piloting motion of the finger and minimizes any threat to the integrity of the condom body by a fingernail during insertion into a passive sexual organ.
- the applicator tube is preferably composed of a disposable rigid material such as glazed cardboard or plastic.
- the applicator tube (like the insertion tube) may be composed of a biocompatible, water soluble, shape-retaining film such as the one described (above) for the insertion element, and may be left in place within the condom body after insertion into the passive sexual organ.
- the closed front end of the applicator tube may contain a releasable encapsulated liquid, e.g. spermicide or lubricant, between a thin burstable outer wall and thin flexible inner wall which is adapted to be released into the inner condom surface by finger pressing against the flexible inner wall in front closed end portion of the applicator tube.
- a releasable encapsulated liquid e.g. spermicide or lubricant
- the receptive condom when compared to conventional condoms and methods of birth control. There is no loss of spontaneity, as the receptive condom can be inserted before foreplay begins. Since the double ring structure remains on the outside of the sexual orifice, with or without gripping the penis, the penis may remain inside and grow soft, with no danger of slipping of the condom or subsequent leakage. The receptive condom may also be left in place for a repeat performance, if desired but repeated usage is generally not recommended. The receptive condom does not have to fit the penis tightly, and therefore loss of sensation is reduced.
- the condom assembly according to the invention is economical and does not require a visit to a clinic or doctor's office.
- Protection from sexually transmitted diseases can be improved over the 17% failure rate of the present male condom, because the problems of slipping, falling off, breakage, and leakage may be rectified by the external ring of the invention, by the looser fit, and by the reduced stress which the receptive condom incurs.
- the receptive condom may include but does not require the use of chemical spermicides or anti-disease medication.
- the invention can be removed after intercourse (unlike the sponge or diaphragm, which must be left in for 6 to 8 hours in order to be effective) -- a definite advantage to women who are susceptible to Toxic Shock Syndrome or allergic reactions to chemicals.
- Figure la shows an unassembled receptive condom and an insertion tube 2 having an open rear end 2a and closed front end
- the receptive condom comprises a condom body 1 having an open end and a closed end and a circular cushioning la ring at the open end.
- Figure lb shows a receptive condom assembly in storage condition wherein the condom body 1 is housed in the insertion tube 2.
- Figure 2 is a partial cross-sectional view of an improved receptive condom comprising a sheath and a circular cushioning ring wherein the sheath is attached to and within the cushioning ring and is positioned midway between the inner and outer circumference of the ring.
- Figure 3a shows an unassembled receptive condom and an insertion tube 2 having an open rear end 2a and closed front end 2b wherein a portion of the condom body 1 is to be partially inserted into insertion tube 2.
- Figure 3b shows a receptive condom assembly in storage condition wherein a portion of the condom body 1 is housed in the insertion tube 2.
- Figure 4a shows the positioning of an applicator 3 into the receptive condom assembly of Figure 3b.
- Figure 4b illustrates a receptive condom assembly having an applicator and shows the interaction between the applicator 3 and a finger 4.
- Figure 5a illustrates a receptive condom assembly having an open-ended insertion tube and an applicator.
- Figure 5b shows the positioning of an applicator 3 into a receptive condom assembly.
- Figure 5c illustrates a receptive condom assembly having an applicator and shows the interaction between the applicator tube and a finger.
- Figure 6 shows an applicator having entrapped or encapsulated liquid at the closed end of the tube.
- Figure 7 illustrates a receptive condom assembly for a condom having a ring at the open end and closed end.
- Figures 8(a-c) illustrate the insertion of a receptive condom assembly having an applicator into a passive sexual organ.
- the invention comprises an assembly of a condom body 1 and an insertion element 2.
- the condom body 1 is generally phallic in shape and is closed at one end 'and open at the other end.
- the condom body may be constructed of latex film materials, natural lamb ceca products, or other materials suitable for use as a condom body.
- the body 1 is larger than that of conventional male condoms so that, when the receptive condom is fully open and extended, it will surround but not actively grip an erect penis.
- any suitable receptive or unisex condom such as the ones described in U.S. Patent Nos. 4,805,604; 4,945,923 and 4,976,273, may be used in making the condom assembly.
- a preferred condom is one having a cushioning ring la affixed to the open end such as the condom described in U.S. Patent No . 4,805,604.
- the present invention provides an improved receptive condom wherein the condom body 1 is attached at position lb within the cushioning ring la and between the inner and outer diameters of the cushioning ring la as shown in Figure 2.
- the cushioning ring may be optionally provided with a thin, inflexible (but not hard) rubber inner ring, such as one described in U.S. Patent No. 4,805,604.
- a thin, inflexible (but not hard) rubber inner ring such as one described in U.S. Patent No. 4,805,604.
- the condom body 1 is placed closed end first into the open rear portion 2a of insertion tube 2, so that the condom body 1 resides within the insertion tube 2 and the cushioning ring la extends outside of the open rear portion 2a of the insertion tube 2.
- the open end 2a of the insertion tube 2 is adapted to receive a finger or an applicator element.
- a rear portion (lc) of the condom body 1 extends outside of the rear portion 2(a) of the insertion tube 2, and is rolled up around the ring la.
- the condom body 1 is placed closed-end first into the open-ended insertion tube 2, so that a front portion 1(b) of the condom body 1 resides within the insertion tube 2.
- a rear portion 1(c) of the condom body l extends outside the rear portion 2(a) of the insertion tube 2, and is rolled up around ring la.
- Figure 3b shows a receptive condom assembly having a portion of the condom body 1 housed in insertion tube 2.
- Figure 4a shows positioning of an applicator element such as applicator tube 3 having an open rear end 3 (a) adapted for receiving and surrounding a finger and a closed end 3 (b) adapted for inserting into the open rear end 2(a) of the inserter tube 2.
- the applicator tube 3 is in co-axial communication with the insertion tube 2 and confronts the inner surface of the open end of the condom housed in the insertion tube 2.
- the diameter of the open rear end portion 2(a) of insertion tube 2 should be slightly larger than that of the closed front end portion 3 (b) of the applicator tube 3 so as to receive and surround the front closed end 3 (b) portion of applicator tube 3.
- the diameter of applicator tube 3 should be sufficient to accommodate a portion of an average adult finger at least partially, preferably completely.
- Figure 4b shows a receptive condom assembly of an insertion tube 2, the condom body 1 and an applicator 3. This Figure also illustrates the insertion of a finger 4 into the open end 3(a) portion of applicator 3.
- a receptive condom assembly is shown wherein condom body 1 is housed in a insertion tube 5 having an open front end 5 (b) and an open rear end 5 (a) .
- the condom body l is placed into the open ended tube 5 so that a front portion 1 (b) of condom body 1 extends from the front end portion 5(b) of the insertion tube and the rear portion 1(c) extends outside of open rear end 5(a) of the insertion tube.
- Portion 1(a) of the condom body 1 may be positioned within insertion tube 5 (not shown) .
- the entire condom body 1 may be housed in insertion tube 5 with the cushioning ring la extending outside of the rear open end 5a (not shown) of the insertion tube 5 in a manner similar to Figure lb.
- Figure 5b shows positioning of an applicator element such as applicator tube 3 having a closed front end 3 (b) portion adapted for insertion into the receptive condom assembly.
- the applicator tube 3 is in co-axial communication with the insertion tube 5 and confronts the inner surface of the open end of the condom housed in the insertion tube 5 in the same manner shown in Figure 4a.
- Figure 5c shows a receptive condom assembly of an insertion tube 5, the condom body 1, and applicator 3. This Figure also illustrates the insertion of a finger 4 into the open end portion 3(a) of applicator 3.
- Figure 6 illustrates another embodiment of an applicator element.
- the closed front end of an applicator tube 7 contains an encapsulated liquid 7(c) between a thin burstable wall 7(b) and a flexible inner wall 7(d).
- the encapsulated liquid composition 7(c) is released, e.g. by bursting, into the inner surface of front portion of the condom body 1 (not shown) housed in an insertion element such as the assemblies shown in Figures lb, 3b, and 5a.
- Suitable liquid compositions for use in the invention include lubricants and spermicides such as nonoxinol-9 and octoxynol, and benzalkonium chloride. See, for example, M.A. Wainberg et al. Arch. AIDS Res. , Vol. 1, pages 57-68 and F. Mendez et al. , ibid, Vol. 4, pages 115-135.
- Figure 7 shows another embodiment of the receptive condom assembly of the present invention.
- a condom body 8 having a thin flexible ring at the closed end 8 (b) and a ring, e.g. a thin flexible ring or cushioning ring, at the open end 8(a) may be delivered into a passive sexual organ, e.g. vagina, by positioning the condom body 8 into an insertion element of the invention, such as an open-end insertion tube 5, so that the ring at position 8 (b) of condom body 8 is partially enclosed in the front open end 5 (b) of the insertion tube and the ring in position- 8 (a) extends from the open rear end 5(a) of the insertion tube.
- an applicator tube (not shown) may be included as part of the receptive condom assembly.
- Figures 8(a-c) illustrates the insertion of the receptive condom assembly into a passive sexual organ, e.g. vagina.
- a condom assembly such as the one shown in Figure 4b is inserted into the opening of a passive sexual organ closed-end first, until the cushioning ring la prevents any further forward motion, Fig. 8a.
- the cushioning ring la is always on the outside of the passive sexual organ.
- a finger inserted into the rear open end 3 (a) of applicator 3 is used to pilot the condom body 1 housed in insertion tube 2, so that the entire condom body l is inside the passive sexual organ, while the rear portion 1(c) of the condom body l continues to surround the front portion 2(a) of the insertion tube 2, Fig. 8b.
- the applicator tube 3 is removed (not shown) , leaving the receptive condom 1 and insertion tube 2 in place inside a passive sexual organ, prior to receiving a penis.
- the preferred applicator is an applicator tube having a closed front end and a open rear end.
- Other suitable applicator elements could also be used, such as the mechanical plunger described in U.S. Patent No. 4,867,176.
- an applicator tube having a closed end is preferred, because it poses less of a threat to the integrity of the condom body due to accidental finger nail puncture and provides a more convenient "one-step" application.
- the insertion element of the present invention may also be used to deliver agents into a bodily orifice, e.g. vagina or rectum.
- Suitable, but non-limiting, agents include spermicides, lubricants, and medicaments for treating infections or irritations.
- These agents may be carried within the insertion element or may be physically affixed to the insertion element, e.g. an insertion tube, as a surface coating or by comminution with the biocompatible water soluble polymer used in making the insertion element.
- the agents are in powdered or dried form to prevent dissolution of the insertion element during storage.
- solutions or suspensions of the agents are used, these may be placed into the insertion tube just prior to insertion into the bodily orifice.
- an assembly for delivering the agent into a bodily orifice is provided and which includes the insertion element and an applicator such as the ones described above.
- the receptive condom assembly of the present invention may be individually packaged and stored in conventional tamper-proof sanitary packaging means for future use.
Landscapes
- Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Abstract
Description
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU51342/93A AU5134293A (en) | 1992-09-23 | 1993-09-21 | Receptive condom assembly |
| EP93922288A EP0719121A1 (en) | 1992-09-23 | 1993-09-21 | Receptive condom assembly |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/950,418 US5433219A (en) | 1992-09-23 | 1992-09-23 | Receptive condom assembly |
| US07/950,418 | 1992-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1994006379A1 true WO1994006379A1 (en) | 1994-03-31 |
Family
ID=25490405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1993/008938 Ceased WO1994006379A1 (en) | 1992-09-23 | 1993-09-21 | Receptive condom assembly |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US5433219A (en) |
| EP (1) | EP0719121A1 (en) |
| AU (1) | AU5134293A (en) |
| CA (1) | CA2145299A1 (en) |
| WO (1) | WO1994006379A1 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885205A (en) | 1996-10-03 | 1999-03-23 | Kassman; Leon B. | Condom exerting lateral pressure on the penis |
| US5902593A (en) * | 1997-10-01 | 1999-05-11 | Kent; Frances B. | Topically applied personal lubricant containing benzalkonium chloride as the active ingredient |
| AU2001284706A1 (en) * | 2000-08-04 | 2002-02-18 | Path | Female condom employing tensegrity principle |
| US6520922B2 (en) | 2001-03-13 | 2003-02-18 | Double H.Ranch Products, Llc | Devices for collecting animal semen and method of use |
| MXPA05002078A (en) * | 2002-09-19 | 2005-09-12 | Path | Soft cling female condom. |
| US20050061328A1 (en) * | 2003-09-22 | 2005-03-24 | Reddy Alla V.K. | Female condom |
| US7161728B2 (en) * | 2003-12-09 | 2007-01-09 | Idc, Llc | Area array modulation and lead reduction in interferometric modulators |
| US7630114B2 (en) * | 2005-10-28 | 2009-12-08 | Idc, Llc | Diffusion barrier layer for MEMS devices |
| KR20070116538A (en) * | 2006-06-05 | 2007-12-10 | 유겐가이샤 코리츠 쇼지 | Insertion aid |
| US7617827B2 (en) * | 2007-05-24 | 2009-11-17 | Condax Llc | Drug delivery dispenser package |
| US20080302367A1 (en) * | 2007-06-07 | 2008-12-11 | Kameka Walker | Oradent |
| US9968481B2 (en) * | 2014-03-14 | 2018-05-15 | Wei Zhang | User friendly female condom and applicator |
| US20170181605A1 (en) | 2015-12-29 | 2017-06-29 | CEEK Enterprises | Sleeve for speculum and use thereof |
| AU2016381698A1 (en) | 2015-12-29 | 2018-07-05 | CEEK Women’s Health, Inc. | Insertable sleeve for speculum and use thereof |
| EP3397133B1 (en) | 2015-12-29 | 2020-04-22 | Ceek Women's Health, Inc. | Speculum with locking mechanism |
| US10456016B2 (en) | 2017-05-05 | 2019-10-29 | CEEK Enterprises | Applicator for a speculum accessory sleeve and use thereof |
| WO2020056297A1 (en) | 2018-09-13 | 2020-03-19 | Clarke Harry S | Self inflating sex aid |
| AU2019359291B2 (en) | 2018-10-11 | 2025-01-30 | Ceek Women's Health, Inc. | Applicator and sleeve accessory for a speculum and use thereof |
| USD924397S1 (en) | 2018-10-11 | 2021-07-06 | Ceek Women's Health, Inc. | Medical device sleeve |
| USD986415S1 (en) | 2020-09-11 | 2023-05-16 | Ceek Women's Health, Inc. | Speculum |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2267030A (en) * | 1939-12-01 | 1941-12-23 | Hill Charles Rapelje | Tampon |
| US4317447A (en) * | 1979-07-19 | 1982-03-02 | Ortho Pharmaceutical Corporation | Drug delivery system |
| US4805604A (en) * | 1987-06-15 | 1989-02-21 | Spery Nanette S | Receptive condom |
Family Cites Families (123)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3128762A (en) * | 1961-08-23 | 1964-04-14 | John C Young | Mechanical contraceptives |
| US3130721A (en) * | 1961-06-26 | 1964-04-28 | John C Young | Mechanical contraceptives |
| US3374788A (en) * | 1965-06-04 | 1968-03-26 | Deseret Pharmaceutical Company | Contraceptive devices and methods |
| US3464409A (en) * | 1965-10-21 | 1969-09-02 | James Murphy | Birth control means |
| US3452749A (en) * | 1966-10-27 | 1969-07-01 | Edwin H Riedell | Contraceptive device |
| DE1617839A1 (en) * | 1967-04-19 | 1971-04-08 | Schering Ag | Method of contraception |
| US3512528A (en) * | 1967-05-29 | 1970-05-19 | Kimberly Clark Co | Expandable tampon |
| US3495589A (en) * | 1967-07-07 | 1970-02-17 | Jennings C Clement | Inflatable genital device |
| JPS516186B1 (en) * | 1967-08-07 | 1976-02-26 | ||
| US3563244A (en) * | 1968-03-15 | 1971-02-16 | Hajime Moribe | Condoms |
| US3639600A (en) * | 1969-08-28 | 1972-02-01 | Upjohn Co | Process of establishing cyclicity in a human female |
| US3640284A (en) * | 1970-01-05 | 1972-02-08 | Philip A De Langis | Apparatus for electrotherapy of the pubococcygeus |
| US3712910A (en) * | 1970-06-12 | 1973-01-23 | Inst Khim Prirodnykh Soldineny | Stereospecific method for preparing estrane compounds of natural configuration |
| US3690310A (en) * | 1971-03-15 | 1972-09-12 | Cancer Res Inst | Method of bioassay of fertility and contraceptive drugs |
| CA939574A (en) * | 1971-05-04 | 1974-01-08 | Leslie W. Donaldson | Incontinent appliance |
| US3822355A (en) * | 1971-12-10 | 1974-07-02 | Biolog Concepts Inc | Novel oral contraceptive method |
| US3836651A (en) * | 1972-02-22 | 1974-09-17 | Biolog Concepts Inc | Novel oral contraceptive combination |
| DE2310963A1 (en) * | 1972-04-14 | 1974-09-05 | Schering Ag | METHOD OF CONTRACTION BY FOLLOWING STAGE COMBINATION PREPARATIONS |
| US3969502A (en) * | 1972-04-14 | 1976-07-13 | Schering Aktiengesellschaft | Method for contraception by the administration of sequential contraceptive preparations |
| US3932635A (en) * | 1972-04-24 | 1976-01-13 | Syntex Corporation | Novel cyclic progestogen-interrupted estrogen oral contraceptive regimens |
| US3942641A (en) * | 1972-05-05 | 1976-03-09 | Syntex Corporation | Dispensing packages containing novel cyclic progestogen-interrupted estrogen oral contraceptive regimens |
| US4102998A (en) * | 1972-10-02 | 1978-07-25 | Morton Gutnick | Process for the prevention of venereal disease |
| US3854475A (en) * | 1973-02-08 | 1974-12-17 | Investors In Ventures Inc | Female contraceptive devices |
| US4066757A (en) * | 1973-03-26 | 1978-01-03 | Ortho Pharmaceutical Corporation | Oral contraceptive regimen |
| US4171358A (en) * | 1974-04-19 | 1979-10-16 | Eli Lilly And Company | Novel contraceptive method |
| US4144334A (en) * | 1974-10-18 | 1979-03-13 | Schering Aktiengesellschaft | Novel α-hydroxy steroids |
| DK136729C (en) * | 1974-10-18 | 1978-05-01 | Schering Ag | ANALOGICAL PROCEDURE FOR THE PREPARATION OF 1ALFA, 17BETA-DIHYDROXY-17BETA-ALKYNYL-4-OESTREN-3-ONERS |
| US3921311A (en) * | 1975-01-06 | 1975-11-25 | Pathfinder Fund | Clinical demonstration model |
| US4009717A (en) * | 1975-06-27 | 1977-03-01 | Allen Clayton H | Retaining fluids |
| US4018919A (en) * | 1975-07-16 | 1977-04-19 | Eli Lilly And Company | Sequential contraceptive method using two types of progestational agents |
| US4275812A (en) * | 1975-10-01 | 1981-06-30 | Poncy Mark P | Surgical glove package and donning method |
| US4098905A (en) * | 1976-08-17 | 1978-07-04 | Halocarbon Products Corporation | Trifluoroethanol as a male contraceptive |
| US4123519A (en) * | 1976-08-17 | 1978-10-31 | Philips Roxane, Inc. | Injectable contraceptive vaccine and method |
| US4122166A (en) * | 1976-08-17 | 1978-10-24 | Philips Roxane, Inc. | Injectable contraceptive and method |
| US4143136A (en) * | 1976-11-20 | 1979-03-06 | Akzona Incorporated | Method of contraception |
| US4219016A (en) * | 1978-12-07 | 1980-08-26 | The Procter & Gamble Company | Vaginal contraceptive |
| US4252787A (en) * | 1976-12-27 | 1981-02-24 | Cambridge Research And Development Group | Anti-fertility composition and method |
| DE2735515A1 (en) * | 1977-08-06 | 1979-02-22 | Hoechst Ag | USE OF LH-RH PEPTIDES AS AN ANTICONCEPTIVE |
| US4100309A (en) * | 1977-08-08 | 1978-07-11 | Biosearch Medical Products, Inc. | Coated substrate having a low coefficient of friction hydrophilic coating and a method of making the same |
| US4119094A (en) * | 1977-08-08 | 1978-10-10 | Biosearch Medical Products Inc. | Coated substrate having a low coefficient of friction hydrophilic coating and a method of making the same |
| US4198976A (en) * | 1977-10-11 | 1980-04-22 | The Procter & Gamble Company | Vaginal contraceptive |
| DE2745680A1 (en) * | 1977-10-11 | 1979-04-12 | Behringwerke Ag | CONTRACEPTIVE MEANS |
| ES232273Y (en) * | 1977-11-23 | 1978-08-01 | INTRAUTERINE DEVICE WITH CONTRACEPTIVE AGENT FOR WOMEN. | |
| US4186742A (en) * | 1978-06-09 | 1980-02-05 | Donald Enterprises, Inc. | Contraceptive-antivenereal disease tampon |
| US4309997A (en) * | 1978-06-09 | 1982-01-12 | Donald Jack W | Contraceptive and/or antivenereal disease tampon |
| US4247552A (en) * | 1979-01-11 | 1981-01-27 | Syntex (U.S.A.) Inc. | Contraceptive compositions and methods employing 1-substituted imidazole derivatives |
| US4277475A (en) * | 1979-01-11 | 1981-07-07 | Syntex (U.S.A.) Inc. | Contraceptive methods employing 1-substituted imidazole derivatives |
| US4439441A (en) * | 1979-01-11 | 1984-03-27 | Syntex (U.S.A.) Inc. | Contraceptive compositions and methods employing 1-substituted imidazole derivatives |
| US4232675A (en) * | 1979-03-29 | 1980-11-11 | Meldahl Edward N | Male contraceptive arrangement |
| FI791598A7 (en) * | 1979-05-14 | 1981-01-01 | Dia Sert Corp | A contraceptive device inserted into the vagina. |
| US4281648A (en) * | 1979-09-24 | 1981-08-04 | Rogers M Maurice | Inflatable condom |
| US4253997A (en) * | 1979-12-17 | 1981-03-03 | American Home Products Corporation | Anti-ovulatory decapeptides |
| US4406853A (en) * | 1980-02-28 | 1983-09-27 | Collagen Development Corporation | Method of preparation of regenerated fiber collagen condom |
| US4349026A (en) * | 1980-02-28 | 1982-09-14 | Collagen Development Corp. | Regenerated fiber collagen condom and method of preparation |
| US4304226A (en) * | 1980-03-03 | 1981-12-08 | The Procter & Gamble Company | Vaginal contraceptive |
| US4332243A (en) * | 1980-04-04 | 1982-06-01 | Morton Gutnick | Devices and methods for the prevention of transmission of venereal disease and non-gonococcal genital infections |
| NO146013C (en) * | 1980-05-13 | 1982-07-14 | Ken Heimreid | URINE LEAD DEVICE |
| US4383993A (en) * | 1980-05-30 | 1983-05-17 | University Of Kentucky Research Foundation | Nasal dosage forms containing natural female sex hormones |
| US4444789A (en) * | 1980-05-30 | 1984-04-24 | University Of Georgia Research Foundation, Inc. | Use of 8-anilino-1-naphthalenesulfonate as a vaginal contraceptive |
| US4381771A (en) * | 1980-07-31 | 1983-05-03 | Kedma, Incorporated | Female contraceptive |
| US4354494A (en) * | 1981-03-09 | 1982-10-19 | Hogin Philip E | Condom having a retention strap |
| US4696294A (en) * | 1981-08-31 | 1987-09-29 | Reyner Franklin C | Contraceptive device and related method |
| US4475910A (en) * | 1981-10-02 | 1984-10-09 | Mentor Corporation | Male condom catheter having adhesive transfer on roller portion |
| US4415585A (en) * | 1982-03-11 | 1983-11-15 | University Of Illinois Foundation | Contraceptive method |
| US4493699A (en) * | 1982-04-08 | 1985-01-15 | Eli Lilly And Company | Contraceptive methods |
| US4432357A (en) * | 1982-06-15 | 1984-02-21 | Pomeranz Mark L | Condom with rheopexic filled deformable chamber |
| US4564006A (en) * | 1982-06-15 | 1986-01-14 | Pomeranz Mark L | Reclosable condom |
| US4498466A (en) * | 1982-06-15 | 1985-02-12 | Pomeranz Mark L | Reclosable condom having sealed chamber with a rheopexic material within |
| US4427669A (en) * | 1982-06-28 | 1984-01-24 | The Board Of Regents Of The University Of Nebraska | Contraceptive |
| US4416822A (en) * | 1982-07-09 | 1983-11-22 | The Upjohn Company | 17β-Difluoromethyl steroids |
| US4476141A (en) * | 1982-07-14 | 1984-10-09 | University Of Georgia Research Foundation, Inc. | Use of N-(6 aminohexyl)-5-chloro-1-naphthalenesulfonamide, N-(6 aminohexyl)-5-chloro-2-naphthalenesulfonamide, and N-(6 aminohexyl)-5-bromo-2-naphthalenesulfonamide as vaginal contraceptives |
| US4470996A (en) * | 1982-07-14 | 1984-09-11 | University Of Georgia Research Foundation, Inc. | Use of N-phenyl-1-naphthylamine as a vaginal contraceptive |
| US4527988A (en) * | 1982-09-20 | 1985-07-09 | Lutz Peter L | Porous contraceptive device with an interstitial liquid |
| US4840624A (en) * | 1982-09-24 | 1989-06-20 | Lee Henry J | Female condom device |
| US4491593A (en) * | 1983-01-27 | 1985-01-01 | Gallegos Alfredo J | Compositions and methods for fertility control |
| US4474769A (en) * | 1983-05-13 | 1984-10-02 | Pfanstiehl Laboratories, Inc. | Chitosan as a contraceptive |
| US4511558A (en) * | 1983-05-16 | 1985-04-16 | University Patents, Inc. | Alpha-lactalbumin contraceptive |
| US4553972A (en) * | 1983-05-20 | 1985-11-19 | Syntex (U.S.A.) Inc. | Disposable intravaginal contraceptive devices releasing 1-substituted imidazoles |
| US4553968A (en) * | 1983-06-09 | 1985-11-19 | Glenna Komis | External male urinary catheter with garment |
| NL8302103A (en) * | 1983-06-13 | 1985-01-02 | Fundatech Sa | INTRAVAGINAL CONTRACEPTIC AGENT. |
| US4601714A (en) * | 1983-07-07 | 1986-07-22 | Burnhill Michael S | Vaginal device |
| US4564362A (en) * | 1983-07-07 | 1986-01-14 | Burnhill Michael S | Vaginal device |
| US4544554A (en) * | 1983-09-26 | 1985-10-01 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| US4530839A (en) * | 1983-09-26 | 1985-07-23 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| US4628051A (en) * | 1983-09-26 | 1986-12-09 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| GB8327562D0 (en) * | 1983-10-14 | 1983-11-16 | Ici Plc | Contraceptive methods |
| GB8423940D0 (en) * | 1984-09-21 | 1984-10-31 | Lrc Products | Sorting articles from bulk |
| US4711235A (en) * | 1984-10-05 | 1987-12-08 | Willis Robert E | Intravaginal device |
| US4585587A (en) * | 1984-10-19 | 1986-04-29 | Northwestern University | Antigenic peptide compounds |
| US4578219A (en) * | 1984-10-19 | 1986-03-25 | Northwestern University | Antigenic peptide compound |
| US4703752A (en) * | 1985-08-23 | 1987-11-03 | Shlomo Gabbay | Contraceptive device |
| US4873996A (en) | 1986-10-06 | 1989-10-17 | Empi, Inc. | Vaginal stimulator for controlling urinary incontinence in women |
| GB8629808D0 (en) | 1986-12-12 | 1987-01-21 | Wilson F G | Health care device |
| US4834113A (en) * | 1987-08-11 | 1989-05-30 | Reddy A V K | Prophylactic device |
| US4993433A (en) | 1987-08-11 | 1991-02-19 | Reddy Alla V K | Prophylactic device |
| US4735621A (en) * | 1987-02-03 | 1988-04-05 | Lasse Hessel | Tubular protective device for protection against transfer of infectious matter during sexual intercourse |
| US5094250A (en) | 1987-03-02 | 1992-03-10 | Chartex International Plc | Tubular protective device for protection against transfer of infectious matter during sexual intercourse |
| US4821741A (en) * | 1987-04-10 | 1989-04-18 | Mohajer Reza S | Barrier contraceptive |
| US4781709A (en) * | 1987-04-27 | 1988-11-01 | Mark Grubman | Aids-preventing condom shield article |
| US4966165A (en) | 1987-05-08 | 1990-10-30 | Anderson Ray C | Unisex condom |
| US4834114A (en) * | 1987-05-19 | 1989-05-30 | Boarman George L | Contraceptive system |
| US4798600A (en) * | 1987-06-12 | 1989-01-17 | Meadows Michael E | Condom device and method for using same |
| US5065771A (en) | 1987-07-06 | 1991-11-19 | Ferguson Jo A | Prophylactic/contraceptive device |
| US4906242A (en) | 1987-07-18 | 1990-03-06 | Thomas Herman A | Apparatus for preventing the spreading of acquired immune deficiency syndrome (aids) |
| US4945923A (en) | 1987-08-27 | 1990-08-07 | Evans Mark I | Contraceptive and prophylactic device |
| US4856534A (en) | 1987-10-19 | 1989-08-15 | Reubin Sorkin | Condom |
| US4966166A (en) | 1987-09-28 | 1990-10-30 | Leffler John T | Prophylactic device and method |
| JPH0162819U (en) | 1987-10-15 | 1989-04-21 | ||
| US4898184A (en) | 1987-10-23 | 1990-02-06 | Boris Skurkovich | Male and female condoms for the prevention of the transmission of AIDS and other venereal deseases |
| US4867176A (en) | 1988-01-19 | 1989-09-19 | Harvey Lash | Female condom |
| JPH01299219A (en) | 1988-05-25 | 1989-12-04 | Eisai Co Ltd | Menfegol-containing drug for preventing infection with human immunodeficiency virus |
| US4875490A (en) | 1988-09-06 | 1989-10-24 | Roberto Quiroz | Intravaginal device |
| US4993431A (en) | 1989-01-06 | 1991-02-19 | Reddy Alla V K | Prophylactic device and method of manufacture |
| US5076287A (en) | 1989-07-14 | 1991-12-31 | Stanley Hochfeld | Conductive condom |
| NL8902873A (en) * | 1989-11-21 | 1991-06-17 | Willem Lodewijk Van Der Valk | TOOL FOR A MALE CONOM, AND A CONOM FOR APPLICATION WITH THIS TOOL. |
| CA2030716C (en) * | 1989-12-27 | 1996-07-02 | Robert L. Billmers | Water disposable tampon applicators and biodegradable compositions for use therein |
| US5113873A (en) | 1990-06-04 | 1992-05-19 | Boarman George L | Contraception and prophylaxis enhancement system |
| US5046489A (en) | 1990-12-18 | 1991-09-10 | Greg Gibson | Prosthetic device |
| US5109871A (en) | 1991-04-01 | 1992-05-05 | Thornton Thomas F | Health product |
| US5163448A (en) * | 1991-04-30 | 1992-11-17 | Family Health International | Condom comprising dispensing structure, and method of making and using the same |
| US5195537A (en) * | 1991-05-10 | 1993-03-23 | Tillotson Corporation | Elastomeric condom |
| US5158556A (en) * | 1991-08-16 | 1992-10-27 | Merlyn Starley | Condom retaining apparatus |
| US5267575A (en) | 1992-08-05 | 1993-12-07 | C.A.R.E. Of Nevada | User-activated vacuum-assisted condom applicator |
-
1992
- 1992-09-23 US US07/950,418 patent/US5433219A/en not_active Expired - Lifetime
-
1993
- 1993-09-21 WO PCT/US1993/008938 patent/WO1994006379A1/en not_active Ceased
- 1993-09-21 CA CA002145299A patent/CA2145299A1/en not_active Abandoned
- 1993-09-21 AU AU51342/93A patent/AU5134293A/en not_active Abandoned
- 1993-09-21 EP EP93922288A patent/EP0719121A1/en not_active Ceased
-
1995
- 1995-06-07 US US08/485,408 patent/US5598852A/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2267030A (en) * | 1939-12-01 | 1941-12-23 | Hill Charles Rapelje | Tampon |
| US4317447A (en) * | 1979-07-19 | 1982-03-02 | Ortho Pharmaceutical Corporation | Drug delivery system |
| US4805604A (en) * | 1987-06-15 | 1989-02-21 | Spery Nanette S | Receptive condom |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP0719121A4 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0719121A1 (en) | 1996-07-03 |
| US5433219A (en) | 1995-07-18 |
| AU5134293A (en) | 1994-04-12 |
| EP0719121A4 (en) | 1996-02-27 |
| CA2145299A1 (en) | 1994-03-31 |
| US5598852A (en) | 1997-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5433219A (en) | Receptive condom assembly | |
| US4805604A (en) | Receptive condom | |
| US4735621A (en) | Tubular protective device for protection against transfer of infectious matter during sexual intercourse | |
| JP3158253B2 (en) | Contraceptive and infection prevention equipment | |
| IL90120A (en) | female condom | |
| US20060278236A1 (en) | Universal unisex safety condom | |
| US5623946A (en) | Tubular protective device for protection against transfer of infectious matter during sexual intercourse | |
| US5094250A (en) | Tubular protective device for protection against transfer of infectious matter during sexual intercourse | |
| US7322358B2 (en) | Soft cling female condom | |
| EP0434690B1 (en) | Condom | |
| US5209242A (en) | Condoms with leading sponges | |
| US5622185A (en) | Barrier device | |
| CN2305969Y (en) | Polyurethane condom for woman | |
| CN211797160U (en) | Condom of comprehensive protection | |
| AU640902B2 (en) | Female condom | |
| JPS63234968A (en) | Contraceptive sanitrary sac for woman | |
| Taylor | Barrier methods of contraception | |
| WO2004052255A1 (en) | Female condom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA VN |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2145299 Country of ref document: CA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1993922288 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWP | Wipo information: published in national office |
Ref document number: 1993922288 Country of ref document: EP |
|
| WWR | Wipo information: refused in national office |
Ref document number: 1993922288 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1993922288 Country of ref document: EP |